This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Celgene Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Marie G Beauchamps: Innovator in Pharmaceutical Sciences
Introduction
Marie G Beauchamps is a notable inventor in the field of pharmaceutical sciences. She has made significant contributions to the development of solid forms for various compounds. Her work is particularly focused on the treatment of diseases and disorders through innovative compositions.
Latest Patents
Marie G Beauchamps holds a patent for a solid form comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-ylamino]-cyclohexan-1-ol. This patent details the compositions of these solid forms, methods of making them, and their uses in treating various diseases and disorders. Although she has 1 patents, her research is crucial in advancing pharmaceutical formulations.
Career Highlights
Marie G Beauchamps is currently associated with Signal Pharmaceuticals, Inc., where she continues her innovative work. Her career is marked by a commitment to improving therapeutic options through her research and development efforts.
Collaborations
Some of her notable coworkers include Robert Hilgraf and Mohit Atul Kothare. Their collaborative efforts contribute to the advancement of pharmaceutical sciences and the development of new treatment methodologies.
Conclusion
Marie G Beauchamps is a dedicated inventor whose work in pharmaceutical sciences is paving the way for new treatment options. Her contributions, although currently limited in patent count, reflect a commitment to innovation and collaboration in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile